Evolva — Evolving the sales model

Evolva (SW: EVE)

Currency in

Last close As at 08/02/2023

0.00 (0.00%)

Market capitalisation

113m

Research: Consumer

Evolva — Evolving the sales model

Evolva has signed a distribution agreement to jointly develop the Brazilian market for resveratrol with its new partner, Tovani Benzaquen, a distributor of food and functional ingredients. Management expects revenues to exceed CHF1.5m over the next 2.5 years. The distribution agreement opens the Brazilian market for resveratrol, thus should result in an uplift in revenue expectations for the product. If successful, we believe the distribution agreement could be extended to other markets in Latin America and the model could eventually be rolled out to new markets in Asia, for example. We believe this is a significant step in Evolva’s commercialisation capabilities under new CEO Christian Wichert, as he instils a sense of urgency into the business and transitions the company to a fully product-based commercial model.

Sara Welford

Written by

Sara Welford

Director, Consumer

Consumer

Evolva

Evolving the sales model

Distribution agreement

Food and beverages

18 May 2022

Price

CHF0.09

Market cap

CHF94m

Net cash (CHFm) at 31 December 2021

11.0

Shares in issue

996.3m

Free float

100%

Code

EVE

Primary exchange

SIX Swiss Exchange

Secondary exchange

OTC US

Share price performance

%

1m

3m

12m

Abs

(12.9)

(32.2)

(51.3)

Rel (local)

(7.4)

(30.2)

(53.7)

52-week high/low

CHF0.19

CHF0.09

Business description

Evolva is a Swiss biotech company focused on the research, development and commercialisation of ingredients based on nature. The company has leading businesses in Flavours and Fragrances, Health Ingredients and Health Protection.

Next events

H122 results

26 August 2022

Analysts

Sara Welford

+44 (0)20 3077 5700

Russell Pointon

+44 (0)20 3077 5700

Evolva is a research client of Edison Investment Research Limited

Evolva has signed a distribution agreement to jointly develop the Brazilian market for resveratrol with its new partner, Tovani Benzaquen, a distributor of food and functional ingredients. Management expects revenues to exceed CHF1.5m over the next 2.5 years. The distribution agreement opens the Brazilian market for resveratrol, thus should result in an uplift in revenue expectations for the product. If successful, we believe the distribution agreement could be extended to other markets in Latin America and the model could eventually be rolled out to new markets in Asia, for example. We believe this is a significant step in Evolva’s commercialisation capabilities under new CEO Christian Wichert, as he instils a sense of urgency into the business and transitions the company to a fully product-based commercial model.

Year end

Revenue (CHFm)

PBT*
(CHFm)

EPS*
(c)

DPS
(c)

P/E
(x)

Yield
(%)

12/20

7.5

(23.4)

(2.9)

0.0

N/A

N/A

12/21

9.9

(24.5)

(2.6)

0.0

N/A

N/A

12/22e

14.9

(13.5)

(1.3)

0.0

N/A

N/A

12/23e

23.4

(8.6)

(0.8)

0.0

N/A

N/A

Note: *PBT and EPS are normalised, excluding amortisation of acquired intangibles, exceptional items and share-based payments.

Resveratrol a growth driver

Resveratrol is currently the main contributor to Evolva’s Health Ingredients business and the CEO sees it as a key product to significantly boost future growth. As a reminder, it is a naturally occurring ingredient, which Evolva produces via fermentation, with applications in dietary supplements, functional beverages, cosmetics, pharmaceuticals and animal health.

Focus on commercialisation

Christian Wichert, who was appointed unexpectedly in mid-February, gave his first impressions of the business at the FY21 results in March and is clearly putting his words into action. He believes Evolva is well-placed to capitalise on the long-term consumer trend of nature-based products, which are in the sweet spot of health, wellness and sustainability. In March he stated that his immediate focus would be on three levers: boosting commercial performance, executing spending and cost discipline and changing the culture to be entrepreneurial, agile and collaborative. The distribution agreement for resveratrol clearly boosts Evolva’s commercial performance, and we expect to see further similar deals in future.

Valuation: Fair value of CHF0.24/share

We continue to value Evolva on a DCF basis with a 25-year model. Our fair value remains unchanged at CHF0.24/share as we make no changes to our model at this stage. As a reminder, nootkatone contributes c 50% of our fair value for Evolva, with most of this coming from its use in pest control.

Exhibit 1: Financial summary

CHF'000s

2019

2020

2021

2022e

2023e

2024e

Year end 31 December

IFRS

IFRS

IFRS

IFRS

IFRS

IFRS

PROFIT & LOSS

Revenue

 

 

11,596

7,541

9,878

14,947

23,368

42,022

Cost of Sales

(6,305)

(9,783)

(19,184)

(9,230)

(12,860)

(23,557)

Gross Profit

5,292

(2,242)

(9,306)

5,717

10,508

18,465

EBITDA

 

 

(12,280)

(16,733)

(23,796)

(9,463)

(4,736)

3,134

Operating Profit (before GW and except.)

(14,067)

(18,397)

(25,095)

(10,653)

(5,758)

2,243

Intangible Amortisation

(6,060)

(6,508)

(7,306)

(7,306)

(7,306)

(7,306)

Exceptionals

0

0

(9,628)

0

0

0

Operating Profit

(20,128)

(24,905)

(42,030)

(17,959)

(13,064)

(5,063)

Net Interest

(1,486)

(4,978)

622

(2,819)

(2,857)

(2,892)

Other financial income

0

0

0

0

0

0

Profit Before Tax (norm)

 

 

(15,553)

(23,375)

(24,473)

(13,472)

(8,616)

(649)

Profit Before Tax (FRS 3)

 

 

(21,614)

(29,882)

(41,408)

(20,778)

(15,922)

(7,955)

Tax

(25)

18

141

0

0

0

Profit After Tax (norm)

(15,578)

(23,357)

(24,332)

(13,472)

(8,616)

(649)

Profit After Tax (FRS 3)

(21,639)

(29,864)

(41,266)

(20,778)

(15,922)

(7,955)

Average Number of Shares Outstanding (m)

770.4

809.3

926.2

1,030.6

1,030.6

1,030.6

EPS - normalised (c)

 

 

(2.0)

(2.9)

(2.6)

(1.3)

(0.8)

(0.1)

EPS - FRS 3 (c)

 

 

(2.8)

(3.7)

(4.5)

(2.0)

(1.5)

(0.8)

Dividend per share (c)

0.0

0.0

0.0

0.0

0.0

0.0

Gross Margin (%)

45.6

-29.7

-94.2

38.2

45.0

43.9

EBITDA Margin (%)

N/A

N/A

N/A

N/A

N/A

N/A

Operating Margin (before GW and except.) (%)

N/A

N/A

N/A

N/A

N/A

N/A

BALANCE SHEET

Fixed Assets

 

 

143,333

133,316

126,068

117,920

109,955

102,136

Intangible Assets

133,939

123,894

113,302

105,996

98,690

91,384

Tangible Assets

7,211

6,914

5,953

5,111

4,451

3,938

Other fixed assets

2,184

2,508

6,814

6,814

6,814

6,814

Current Assets

 

 

48,745

33,577

34,410

17,028

17,672

30,357

Stocks

5,392

9,125

16,269

12,705

12,852

23,112

Debtors

1,480

2,347

4,502

2,541

3,038

5,463

Cash

39,920

19,669

11,857

0

0

0

Other current assets

1,954

2,435

1,782

1,782

1,782

1,782

Current Liabilities

 

 

(12,295)

(15,139)

(15,221)

(13,340)

(14,026)

(16,047)

Creditors

(2,912)

(2,128)

(3,625)

(1,744)

(2,430)

(4,451)

Short term borrowings

0

0

0

0

0

0

Finance lease obligations

(1,289)

(1,059)

(834)

(834)

(834)

(834)

Other current liabilities

(8,095)

(11,952)

(10,762)

(10,762)

(10,762)

(10,762)

Long Term Liabilities

 

 

(7,221)

(6,662)

(28,383)

(23,633)

(10,006)

(20,657)

Long term borrowings

0

0

(19,200)

(19,200)

(6,403)

(17,884)

Finance lease obligations

(4,840)

(4,179)

(3,574)

(2,744)

(1,914)

(1,083)

Other long term liabilities

(2,381)

(2,484)

(5,609)

(1,689)

(1,689)

(1,689)

Net Assets

 

 

172,562

145,092

116,875

97,976

103,595

95,789

CASH FLOW

Operating Cash Flow

 

 

(13,577)

(22,317)

(29,355)

(5,670)

(4,546)

(7,382)

Net Interest

(583)

(1,046)

(431)

(2,819)

(2,857)

(2,892)

Capex

(193)

(1,223)

(335)

(349)

(363)

(377)

Acquisitions/disposals

0

0

0

0

0

0

Financing

164

0

7,500

0

0

0

Dividends

0

0

0

0

0

0

Other cash flow

(6,224)

4,479

13,917

(830)

(830)

(830)

Net Cash Flow

(20,413)

(20,106)

(8,704)

(9,667)

(8,596)

(11,481)

Opening net debt/(cash)

 

 

(60,381)

(39,920)

(19,670)

(11,005)

(1,337)

7,259

HP finance leases initiated

0

0

0

0

0

0

Other

(47)

(144)

39

0

0

0

Closing net debt/(cash)

 

 

(39,920)

(19,670)

(11,005)

(1,337)

7,259

18,739

Source: Edison Investment Research, company data


General disclaimer and copyright

This report has been commissioned by Evolva and prepared and issued by Edison, in consideration of a fee payable by Evolva. Edison Investment Research standard fees are £60,000 pa for the production and broad dissemination of a detailed note (Outlook) following by regular (typically quarterly) update notes. Fees are paid upfront in cash without recourse. Edison may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.

Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained in this report represent those of the research department of Edison at the time of publication. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.

Exclusion of Liability: To the fullest extent allowed by law, Edison shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained on this note.

No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in the report may not be eligible for sale in all jurisdictions or to certain categories of investors.

Investment in securities mentioned: Edison has a restrictive policy relating to personal dealing and conflicts of interest. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report, subject to Edison's policies on personal dealing and conflicts of interest.

Copyright: Copyright 2022 Edison Investment Research Limited (Edison).

Australia

Edison Investment Research Pty Ltd (Edison AU) is the Australian subsidiary of Edison. Edison AU is a Corporate Authorised Representative (1252501) of Crown Wealth Group Pty Ltd who holds an Australian Financial Services Licence (Number: 494274). This research is issued in Australia by Edison AU and any access to it, is intended only for "wholesale clients" within the meaning of the Corporations Act 2001 of Australia. Any advice given by Edison AU is general advice only and does not take into account your personal circumstances, needs or objectives. You should, before acting on this advice, consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If our advice relates to the acquisition, or possible acquisition, of a particular financial product you should read any relevant Product Disclosure Statement or like instrument.

New Zealand

The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (i.e. without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision.

United Kingdom

This document is prepared and provided by Edison for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "FPO") (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document.

This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.

United States

Edison relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Edison does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

1185 Avenue of the Americas

3rd Floor, New York, NY 10036

United States of America

Sydney +61 (0)2 8249 8342

Level 4, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

1185 Avenue of the Americas

3rd Floor, New York, NY 10036

United States of America

Sydney +61 (0)2 8249 8342

Level 4, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

General disclaimer and copyright

This report has been commissioned by Evolva and prepared and issued by Edison, in consideration of a fee payable by Evolva. Edison Investment Research standard fees are £60,000 pa for the production and broad dissemination of a detailed note (Outlook) following by regular (typically quarterly) update notes. Fees are paid upfront in cash without recourse. Edison may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.

Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained in this report represent those of the research department of Edison at the time of publication. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.

Exclusion of Liability: To the fullest extent allowed by law, Edison shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained on this note.

No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in the report may not be eligible for sale in all jurisdictions or to certain categories of investors.

Investment in securities mentioned: Edison has a restrictive policy relating to personal dealing and conflicts of interest. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report, subject to Edison's policies on personal dealing and conflicts of interest.

Copyright: Copyright 2022 Edison Investment Research Limited (Edison).

Australia

Edison Investment Research Pty Ltd (Edison AU) is the Australian subsidiary of Edison. Edison AU is a Corporate Authorised Representative (1252501) of Crown Wealth Group Pty Ltd who holds an Australian Financial Services Licence (Number: 494274). This research is issued in Australia by Edison AU and any access to it, is intended only for "wholesale clients" within the meaning of the Corporations Act 2001 of Australia. Any advice given by Edison AU is general advice only and does not take into account your personal circumstances, needs or objectives. You should, before acting on this advice, consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If our advice relates to the acquisition, or possible acquisition, of a particular financial product you should read any relevant Product Disclosure Statement or like instrument.

New Zealand

The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (i.e. without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision.

United Kingdom

This document is prepared and provided by Edison for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "FPO") (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document.

This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.

United States

Edison relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Edison does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

1185 Avenue of the Americas

3rd Floor, New York, NY 10036

United States of America

Sydney +61 (0)2 8249 8342

Level 4, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

1185 Avenue of the Americas

3rd Floor, New York, NY 10036

United States of America

Sydney +61 (0)2 8249 8342

Level 4, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

More on Evolva

View All

Consumer

Evolva — Evolving the sales model

Consumer

Evolva — A new era

Latest from the Consumer sector

View All Consumer content
Treatt_resized

Consumer

Treatt — Back to steady growth

Consumer

ConsumerWatch – January 2023

Consumer

Agrana — Good nine-month performance

Research: Metals & Mining

Pan American Silver — Q122 results – good cost control

Pan American Silver’s (PAAS’s) Q122 financial results were supported by strong gold and silver sales, while production was affected by the latest COVID-19 outbreak. The company maintained its guidance for FY22 and expects production to be second-half weighted. Costs were generally under control, with an impressive cost performance in the silver segment. Although PAAS is seeing increased cost pressures, its full-year cost expectations remained unchanged. We have updated our estimates to reflect the results and lower commodity prices, reducing our valuation from US$31.0/share to US$29.5/share. Following the recent weakness, the shares look attractive at an FY22e EV/EBITDA of 7.5x.

Continue Reading

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free